Transgenic Mosquitoes for Improved Malaria Sporozoite Vaccine Manufacture
SANARIA INC. · Department of Health and Human Services
Phase II2012$2,955,385
DESCRIPTION (provided by applicant): An ideal tool for eliminating Plasmodium falciparum (Pf), the causative agent of 99% of all malaria deaths, would be a highly effective vaccine that prevents blood stage infection an…